Dwr Cymru Welsh Water supplies over three million people with drinking water throughout most of Wales (UK). Ortho-phosphate has increasingly been dosed at around 1 mg/L (P) to further reduce the corrosivity of supplies to the lead pipes which connect approximately 30% of houses to water mains in the company's area, additional to long-establish pH adjustment measures. The installation of new orthophosphate dosing schemes and the optimisation of these and existing dosing schemes, 29 schemes in total, were subject to a regulatory programme of work, agreed with the Drinking Water Inspectorate (DWI). Optimisation comprised (i) selection of appropriate ortho-phosphate doses by a procedure involving laboratory based plumbosolvency testing linked to zonal lead emission (compliance) modelling, (ii) tight dose control and (iii) extensive monitoring of lead in supply by random daytime (RDT) sampling and by the use of lead pipe test rigs. The successful outcome was confirmed by 99% of over 5,000 RDT samples complying with the future standard of 10 mg/L for lead in drinking water.
INTRODUCTION
Dwr Cymru Welsh Water supplies most of Wales with drinking water with its potable operational activities out-sourced to United Utilities Operational Services Ltd. The area supplied within Wales is shown in Figure 1 . Over three million people and industry are supplied by an average of 900 Mld. The water supply system extends to 81 impounding reservoirs, 105 water treatment works, 27,000 km of water mains, 532 pumping stations and 715 service reservoirs. Most of the water abstracted is surface derived with only a small proportion of groundwater. About 75% of the surface water is low in alkalinity, being mostly derived from rural uplands, and prior to treatment is typically slightly acidic with organic colour contents as high as 308H. The remaining surface water, mainly from the south-eastern part of Wales, has a higher alkalinity and generally less organic colour, reflecting the greater lowland characteristics of these waters. From the late 1970s, the former Welsh Water Authority adopted a treatment policy of pH adjustment to . 8.0 for all surface derived waters, achieved at most works by lime dosing. In this era, the standard for lead in drinking water was taken to be 100 mg/L from WHO guidelines doi: 10.2166/wh.2008.044 (World Health Organization 1970 ) and the pH adjustment policy was found to be generally successful.
In 1985, the standards of the first European "drinking water" directive (European Commission 1980) became a legal requirement, including a standard for lead of 50 mg/L as a "maximum admissible concentration" in "running water".
The standards of this directive were implemented by regulations in 1989 (UK Government 1989) and the interpretation given in associated Government guidelines (Department of the Environment 1989) was that the lead standard would be assessed by random-daytime, first-draw (RDT) sampling. This guidance also required water companies to undertake RDT surveys to achieve minimum specified amounts of lead data, if it was not already available, by mid-1991, and to initiate further corrective action if appropriate. In consequence, ortho-phosphate dosing at 1 mg/L(P) was initiated in the mid-1990s at 30 works.
A number of these works have since been abandoned.
The revised "drinking water" directive (European phosphate dosing schemes were not subject to a regulatory programme but were also optimised. The total of the 39 treatment works where ortho-phosphate is now dosed accounts for 90% of the company's supplies by volume. This paper outlines how the company optimised this orthophosphate dosing and the outcomes which were achieved, using the Talybont supply as an illustrative example.
METHODOLOGY AND RESULTS
The approach taken to optimisation followed the guidance issued to water companies in England and Wales (Drinking 
Optimisation strategy
The guidance issued by the Drinking Water Inspectorate in relation to plumbosolvency control by treatment measures (Drinking Water Inspectorate 2000 , 2001 ) provided a generalised framework for achieving and demonstrating optimisation. It required or implied that water quality in supply needed to be of generally good quality and that appropriate doses of ortho-phosphate and a suitable pH condition needed to be maintained. Of greatest relevance to general water quality were iron discolouration and the presence of organics, particularly humic and fulvic acids.
Assuming that water quality was of generally good quality, the biggest challenges were the selection of ortho-phosphate dose and its routine operational achievement.
The Inspectorate's guidance on the definition of optimisation (Drinking Water Inspectorate 2000 , 2001 ) is mostly directional but does include the criterion that no more than 2% of RDT samples for lead should exceed 10 mg/L, for a scheme to be considered optimised. This criterion was the focus of the company's strategy, allied to correct ortho-phosphate dose selection and its regular achievement.
Ortho-phosphate dose selection
In an ideal world, a single universal dose of orthophosphate would be applied based on industry-wide experience. Whilst a common dose of 1.0 mg/L(P) was used by many water companies in relation to achieving compliance with the earlier standard of 50 mg/L, including Dwr Cymru Welsh Water, more recent experience of aiming for compliance with 10 mg/L has indicated (Hayes et al. 2006 ) that doses need to be more precisely tuned to individual waters. The simplest approach to dose selection would be to adjust the dose up and down operationally until the lead concentrations observed in a zone were satisfactory for the least dose possible (so as to minimise operating cost and any environmental impact). In practice, there can be a problem because of the prolonged time it may take for the lead pipes in a zone to equilibrate with the ortho-phosphate dose applied, ranging from a few months to several years (Hayes 2004) . In consequence, a simple control loop for ortho-phosphate dosing may be denied.
A more sophisticated approach was adopted by Dwr Cymru Welsh Water in the selection of water-specific orthophosphate doses, involving laboratory based plumbosolvency testing and zonal lead emission modelling.
Laboratory plumbosolvency testing was undertaken by the standard method developed by Colling et al. (1987 Colling et al. ( , 1992 for the major works requiring ortho-phosphate dosing and for a representative selection of the minor works requiring ortho-phosphate dosing. Testing involves pumping test water through sections of new lead piping at 258C with a water-pipe contact time of 30 minutes and measuring the lead emissions over a four week period. At the end of the test period, the water is allowed to stagnate in the lead piping for 16 hours and then sampled, to provide an indication of the lead solubility equilibrium concentration.
For the major works, testing was undertaken for a range of ortho-phosphate doses over a range in pH conditions. Typical results are illustrated by Table 1 and show the expected benefit of increased pH without ortho-phosphate with this low alkalinity water, that pH is less important when ortho-phosphate is dosed and that the responses of the water to increasing ortho-phosphate doses follow a declining exponential curve in approximate terms. The results in Table 1 only give an indication of the ortho-phosphate dose which might be required and not a precise determination; for example, at pH 8.0 the optimum dose is most likely greater than 0.6 mg/L (P) but could be between 0.9 and 1.5 mg/L (P).
However, the shape of the phosphate response curve does provide important diagnostic information.
For 20 treated waters from across Wales, the results of testing different ortho-phosphate doses at pH 7.5 are summarised in Table 2 The validation was good to excellent in most cases as illustrated by the example for the Talybont supply in Table 3 (in a few cases the zonal model was calibrated to achieve a good match between the simulated and actual RDT data) from which it was concluded that the model could be used to investigate different percentage reductions in plumbosolvency (eg: as would result in curves A, B and C in Figure 2 ) and the likely result of different ortho-phosphate doses.
An example of the relationship between simulated RDT sample results and reductions in plumbosolvency is given in Table 4 for the same Talybont supply. It can be seen in Table 4 by interpolation that an 87% reduction (in between conditions In this latter respect, the percentage of houses with a lead pipe was estimated to range from 8 to 65% with an average of 28%. The average dose of ortho-phosphate needed to achieve the DWI criterion ranged from 0.6 to 1.5 mg/L (P)
with an average of 0.9 mg/L (P) across the 39 dosing schemes, close to the earlier standard assumption.
Operational control
At most schemes, ortho-phosphate is dosed using orthophosphoric acid (75%) and a dosing pump which is proportional to the variable treated water flow from the works. At a few works the more neutral mono-sodium di-hydrogen phosphate salt is dosed as a 32% liquor. An on-line phosphate monitor is in use, sampling after phosphate injection, results being displayed both locally and at a central control point (via telemetry) but the results are not used to control the dosing pump.
The phosphate set points of the dosing system have been set to achieve the average required dose but applied as a RDT sampling for lead is not very reproducible, particularly for waters prior to ortho-phosphate dosing, but once orthophosphate dosing had been established reproducibility was much better, as illustrated by Table 5 for the Talybont supply. By bulking RDT lead results for several years, these reproducibility problems can be diminished. Samples intermittently replenish a sampling container so that fresh samples are always available for collection.
The rigs supplied by ProMinent performed satisfactorily once the flushing times had been adjusted to their maximum, to minimise lead concentrations prior to the stagnation cycle.
The rigs from HMS were more problematical due to their 2. The need to consider the replacement of lead pipes in order to achieve compliance with the EU Directive and associated UK regulations has therefore been much reduced.
3. Comprehensive public health protection has been achieved at a substantially lower cost than would be incurred by the replacement of lead pipes.
